Bulk APIs, Generics

  • Manufacture of quality Active Pharmaceutical Ingredients (APIs) and intermediates
  • Expertise in process optimization and large scale cGMP production
  • An offering of over 25 APIs
  • Substantial regulatory expertise and support
  • Development of DMFs, CTDs for advanced intermediates and final APIs
  • Strong technology offering to both the generic and ethical pharmaceutical industry


Dishman counts amongst its customers major ethical and generic companies operating in the pharmaceutical industry. We continue to invest in capabilities and facilities to maintain a strong technology offering to both the ethical pharmaceutical and generic industries. Dishman Specialty Chemicals offer a range of bulk APIs and intermediates for commercial application.



5 November 2018
Dishman Carbogen Amcis Ltd. Announces a Successful FDA Inspection of its Site in Bavla, India

1 August 2018
Dishman Carbogen Amcis Opens Office in Kyoto, Japan

11 August 2016
Dishman Celebrates a Decade of Success Since Acquisition of CARBOGEN AMCIS